TY - JOUR
T1 - Race and ethnicity in cancer therapy
T2 - What have we learned?
AU - Grenade, C.
AU - Phelps, M. A.
AU - Villalona-Calero, M. A.
PY - 2014/4
Y1 - 2014/4
N2 - Racial and ethnic disparities in the pathogenesis of common malignancies and outcomes from treatment remain a major health concern. Factors attributed to these disparities include differences in lifestyle, environment, genetics, and tumor biology. As we strive to personalize cancer therapy, it will be imperative that we understand the relative contributions of each factor so that we may apply this knowledge in choosing the best treatment for each individual, regardless of his or her racial or ethnic heritage.
AB - Racial and ethnic disparities in the pathogenesis of common malignancies and outcomes from treatment remain a major health concern. Factors attributed to these disparities include differences in lifestyle, environment, genetics, and tumor biology. As we strive to personalize cancer therapy, it will be imperative that we understand the relative contributions of each factor so that we may apply this knowledge in choosing the best treatment for each individual, regardless of his or her racial or ethnic heritage.
UR - http://www.scopus.com/inward/record.url?scp=84897025767&partnerID=8YFLogxK
U2 - 10.1038/clpt.2014.5
DO - 10.1038/clpt.2014.5
M3 - Review article
C2 - 24419564
AN - SCOPUS:84897025767
SN - 0009-9236
VL - 95
SP - 403
EP - 412
JO - Clinical Pharmacology and Therapeutics
JF - Clinical Pharmacology and Therapeutics
IS - 4
ER -